down arrow

Aarey Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE198H01019
  • NSEID: AAREYDRUGS
  • BSEID: 524412
INR
76.44
-4.01 (-4.98%)
BSENSE

Dec 05

BSE+NSE Vol: 33.73 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Aarey Drugs & Pharmaceuticals Ltd stock-summary
stock-summary
Aarey Drugs & Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company.
Company Coordinates stock-summary
Company Details
E-34 MIDC Tarapur, Boisar Thane Maharashtra : 401506
stock-summary
Tel: 91-22-23455543
stock-summary
http://www.aareydrugs.com
stock-summary
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 25.38 Cr
Number of Shares
2.54 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
25-Nov-2021
2.54
25.38
2000000
10
Preferential basis
20-Mar-2018
2.34
23.38
3300000
10
QIB Equity Shares
14-Sep-2017
2.01
20.08
2000000
10
Allotment of Equity To Others
20-Mar-2017
1.81
18.08
505000
10
Allotment of Equity To Others
20-Mar-2017
1.81
18.08
505000
10
Allotment of Equity To Others
05-Aug-2016
1.76
17.58
765000
10
Conversion of Warrants
25-Jun-2012
1.68
16.81
2802447
10
Bonus
25-Jun-2012
1.68
16.81
2802447
10
Bonus
19-Jan-2012
1.4
14.01
9011837
10
Right Issues
19-Jan-2012
1.4
14.01
9011837
10
Right Issues
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (1.13%)

Promoter with highest holding

Bina Rajesh Ghatalia (14.12%)

Highest Public shareholder

Krishnamurthy C G (1.73%)

Individual Investors Holdings

47.01%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Mihir R Ghatalia
Chairman & Managing Director
10.51 lacs
Chetan K Mehta
Independent Director
0
Preeti Paresh Rathi
Company Sec. & Compli. Officer
0
Lalit Tulsiani
Independent Director
0
Nimit R Ghatalia
Executive Director
7.78 lacs
Anil Mandal
Independent Director
0
Bina Ghatalia
Additional Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchases
464.6626
0%
 
100
Purchases
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Chemical - Traded
349.35
100.00%
 
100
Chemical - Traded
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
84 Cr
(Quarterly Results - Sep 2025)
Net Profit:
1 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 218 Cr (Micro Cap)

stock-summary
P/E

64.00

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.30

stock-summary
Return on Equity

2.47%

stock-summary
Price to Book

1.58

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."